Mirati Therapeutics
Utility Patents

Last updated:

List of all Mirati Therapeutics patents 5 in total

Status Patent
Grant
Utility: Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors External link
Filling date: 6 Sep 2025 Issue date: 11 Jan 2022
Grant
Utility: Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors External link
Filling date: 6 Sep 2025 Issue date: 17 Aug 2021
Grant
Utility: KRas G12C inhibitors External link
Filling date: 6 Sep 2025 Issue date: 23 Jun 2020
Grant
Utility: KRas G12C inhibitors External link
Filling date: 6 Sep 2025 Issue date: 12 May 2020
Grant
Utility: KRas G12C inhibitors External link
Filling date: 6 Sep 2025 Issue date: 28 Apr 2020

Showing 1 to 5 of 5 patents.